Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
107,24 €
+2,72 €
+2,60%
30.04.26
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
66 %
Index-Zuordnung
Nasdaq Composite Index
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,94: MM6SGD
Werbung

Illumina News

10.11.25 - PR Newswire
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks PR Newswire
05.11.25 - PR Newswire
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Illumina Responds to Positive Updates from Chinese Ministry of Commerce PR Newswire
30.10.25 - PR Newswire
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 PR Newswire
15.10.25 - PR Newswire
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights PR Newswire
15.10.25 - PR Newswire
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-​to-see genomic insights in GeneDx pilot PR Newswire
14.10.25 - PR Newswire
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 PR Newswire
01.10.25 - PR Newswire
Illumina launches new business to accelerate technology and data-driven discovery
Illumina launches new business to accelerate technology and data-​driven discovery PR Newswire
23.09.25 - PR Newswire
Illumina advances personalized cancer care with new pharma development partnerships
Illumina advances personalized cancer care with new pharma development partnerships PR Newswire
18.09.25 - PR Newswire
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine PR Newswire
15.09.25 - LYNX Analysen
Illumina: Endlich wieder auf Erfolgskurs?
Illumina hat eine turbulente Geschichte hinter sich. Die jüngsten Quartals­zahlen deuten jedoch auf eine Rückkehr zu alter Stärke hin. Jetzt vollständige Analyse lesen
07.09.25 - PR Newswire
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
31.07.25 - PR Newswire
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 PR Newswire
30.07.25 - PR Newswire
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling PR Newswire
10.07.25 - PR Newswire
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 PR Newswire
10.07.25 - PR Newswire
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year PR Newswire
23.06.25 - PR Newswire
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy PR Newswire
10.06.25 wallstreetONLINE Redaktion
Aktie vor Turnaround?: Keine Geduld mehr mit Bayer und Evotec? Diese Aktie könnte die Lösung sein!
Turnaround-​Wetten kosten viel Zeit, Nerven – und oft auch Geld. Vor allem Evotec und Bayer enttäuschten zuletzt immer wieder. Deutlich aussichtsreicher könnte jetzt Gen- und ...
10.06.25 - PR Newswire
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »